Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2026-05-27 16:30:15 ET · period of report 2026-05-22 · accession 0001193125-26-241984 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 16:30 | 2026-05-22 | PHAT | Parikh Asit | Dir | G - Gift | $0.00 | -28.0K | 24.1K | -54% | $0 | |
| I | 2026-05-27 16:30 | 2026-05-22 | PHAT | Parikh Asit | Dir | G - Gift | $0.00 | +28.0K | 148.5K | +23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-22 | G | D | 28,000 | $0.00 | 24,122 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-22 | G | A | 28,000 | $0.00 | 148,500 | I by Trust | — | — | (F1) Reflects shares transferred for no consideration to a trust for the benefit of the Reporting Person's spouse and for which the Reporting Person serves as trustee. |